Despite their efficacy in cancer treatment, some researchers have recently proposed that inhibition of PARP can be considered an innovative approach for treating metabolic disorders, cardiovascular diseases, testicular damage, and nephropathies [87,88,89,90]. This evidence concerns the gene PARP1 and cancer.